Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 20 | 2025 | 121 | 5.840 |
Why?
|
| Cognition | 15 | 2025 | 81 | 2.770 |
Why?
|
| Stroke | 10 | 2025 | 309 | 2.510 |
Why?
|
| Depression | 12 | 2025 | 486 | 2.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2022 | 118 | 1.840 |
Why?
|
| Aging | 8 | 2025 | 160 | 1.750 |
Why?
|
| Cognitive Dysfunction | 9 | 2025 | 53 | 1.690 |
Why?
|
| Educational Status | 4 | 2024 | 177 | 1.680 |
Why?
|
| Neuropsychological Tests | 7 | 2025 | 43 | 1.540 |
Why?
|
| Stress Disorders, Post-Traumatic | 9 | 2019 | 68 | 1.520 |
Why?
|
| Male | 49 | 2025 | 9804 | 1.380 |
Why?
|
| Female | 57 | 2025 | 12396 | 1.370 |
Why?
|
| Executive Function | 7 | 2025 | 23 | 1.340 |
Why?
|
| Humans | 72 | 2025 | 17314 | 1.320 |
Why?
|
| Risk Factors | 27 | 2025 | 3258 | 1.240 |
Why?
|
| Aged | 40 | 2025 | 6084 | 1.220 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 1925 | 1.160 |
Why?
|
| Cohort Studies | 26 | 2025 | 2514 | 1.120 |
Why?
|
| Longitudinal Studies | 17 | 2025 | 674 | 1.080 |
Why?
|
| Middle Aged | 38 | 2025 | 7836 | 1.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2025 | 165 | 1.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2025 | 664 | 0.980 |
Why?
|
| Stress, Psychological | 4 | 2019 | 134 | 0.820 |
Why?
|
| Memory, Episodic | 5 | 2025 | 6 | 0.790 |
Why?
|
| Cardiovascular Diseases | 6 | 2018 | 532 | 0.760 |
Why?
|
| Residence Characteristics | 5 | 2024 | 253 | 0.760 |
Why?
|
| Incidence | 14 | 2025 | 1266 | 0.750 |
Why?
|
| Proportional Hazards Models | 12 | 2025 | 701 | 0.740 |
Why?
|
| Healthy Aging | 4 | 2023 | 8 | 0.740 |
Why?
|
| Hypertension | 4 | 2023 | 469 | 0.730 |
Why?
|
| Hypoglycemia | 2 | 2019 | 46 | 0.700 |
Why?
|
| African Americans | 5 | 2021 | 439 | 0.680 |
Why?
|
| Alzheimer Disease | 3 | 2025 | 49 | 0.660 |
Why?
|
| Sleep | 1 | 2020 | 57 | 0.630 |
Why?
|
| California | 11 | 2025 | 2311 | 0.600 |
Why?
|
| Continental Population Groups | 1 | 2019 | 286 | 0.540 |
Why?
|
| Sex Characteristics | 1 | 2017 | 66 | 0.540 |
Why?
|
| Adult | 19 | 2025 | 7500 | 0.540 |
Why?
|
| Machine Learning | 3 | 2025 | 53 | 0.510 |
Why?
|
| Prospective Studies | 11 | 2021 | 1226 | 0.500 |
Why?
|
| Sex Factors | 5 | 2024 | 603 | 0.500 |
Why?
|
| Longevity | 5 | 2022 | 12 | 0.470 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 224 | 0.450 |
Why?
|
| Health Status | 1 | 2016 | 293 | 0.450 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 1151 | 0.420 |
Why?
|
| Income | 3 | 2024 | 86 | 0.380 |
Why?
|
| Time Factors | 7 | 2019 | 1039 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 102 | 0.320 |
Why?
|
| Risk | 4 | 2021 | 496 | 0.310 |
Why?
|
| C-Reactive Protein | 3 | 2017 | 58 | 0.300 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2017 | 5 | 0.280 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2017 | 8 | 0.280 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2017 | 9 | 0.280 |
Why?
|
| Adult Survivors of Child Adverse Events | 2 | 2018 | 4 | 0.280 |
Why?
|
| Memory | 2 | 2025 | 12 | 0.270 |
Why?
|
| Self Report | 2 | 2020 | 257 | 0.260 |
Why?
|
| Psychological Trauma | 2 | 2016 | 6 | 0.260 |
Why?
|
| Triglycerides | 2 | 2025 | 83 | 0.250 |
Why?
|
| Cross-Sectional Studies | 8 | 2025 | 1280 | 0.250 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2025 | 8 | 0.240 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2025 | 4 | 0.240 |
Why?
|
| United States | 10 | 2025 | 3866 | 0.240 |
Why?
|
| Hippocampus | 1 | 2025 | 8 | 0.230 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 605 | 0.230 |
Why?
|
| Hearing Loss | 1 | 2025 | 18 | 0.230 |
Why?
|
| Walking Speed | 1 | 2024 | 3 | 0.230 |
Why?
|
| Cholesterol, HDL | 1 | 2025 | 69 | 0.230 |
Why?
|
| Brain | 1 | 2024 | 48 | 0.220 |
Why?
|
| Nurses | 3 | 2019 | 33 | 0.220 |
Why?
|
| Social Class | 3 | 2021 | 116 | 0.210 |
Why?
|
| Insurance, Health | 1 | 2025 | 170 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 1282 | 0.210 |
Why?
|
| Life Style | 1 | 2025 | 316 | 0.210 |
Why?
|
| Hypoglycemic Agents | 1 | 2025 | 250 | 0.200 |
Why?
|
| Internal-External Control | 2 | 2020 | 11 | 0.190 |
Why?
|
| Biomarkers | 5 | 2025 | 307 | 0.190 |
Why?
|
| Desegregation | 1 | 2021 | 1 | 0.180 |
Why?
|
| Ethnic Groups | 3 | 2021 | 451 | 0.180 |
Why?
|
| Cognitive Aging | 1 | 2021 | 1 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2025 | 2415 | 0.180 |
Why?
|
| Child | 9 | 2023 | 2403 | 0.180 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 27 | 0.170 |
Why?
|
| Frailty | 1 | 2021 | 11 | 0.170 |
Why?
|
| Parents | 2 | 2017 | 297 | 0.170 |
Why?
|
| Antidepressive Agents | 2 | 2019 | 142 | 0.170 |
Why?
|
| Inflammation | 2 | 2017 | 63 | 0.170 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2020 | 6 | 0.170 |
Why?
|
| Glycated Hemoglobin A | 2 | 2018 | 184 | 0.170 |
Why?
|
| Southeastern United States | 2 | 2017 | 9 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 34 | 0.160 |
Why?
|
| Social Mobility | 1 | 2019 | 2 | 0.160 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2019 | 13 | 0.160 |
Why?
|
| Hand Strength | 1 | 2019 | 10 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 452 | 0.160 |
Why?
|
| Television | 1 | 2019 | 16 | 0.150 |
Why?
|
| Walking | 1 | 2019 | 89 | 0.150 |
Why?
|
| Independent Living | 3 | 2025 | 24 | 0.150 |
Why?
|
| Age Factors | 2 | 2018 | 878 | 0.150 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 16 | 0.140 |
Why?
|
| Retirement | 1 | 2017 | 5 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 390 | 0.140 |
Why?
|
| Health | 1 | 2017 | 32 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2017 | 397 | 0.140 |
Why?
|
| Telomere Shortening | 1 | 2017 | 3 | 0.130 |
Why?
|
| Psychometrics | 1 | 2017 | 119 | 0.130 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 6 | 0.130 |
Why?
|
| Poverty Areas | 1 | 2017 | 21 | 0.130 |
Why?
|
| Taxes | 1 | 2017 | 23 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2018 | 314 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 65 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 21 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2016 | 937 | 0.120 |
Why?
|
| Exercise | 2 | 2020 | 515 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 44 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 53 | 0.120 |
Why?
|
| Child Abuse | 1 | 2015 | 43 | 0.120 |
Why?
|
| Positron-Emission Tomography | 2 | 2025 | 33 | 0.120 |
Why?
|
| Geriatric Assessment | 2 | 2025 | 43 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 202 | 0.110 |
Why?
|
| HIV Infections | 1 | 2021 | 712 | 0.110 |
Why?
|
| Smoking | 1 | 2017 | 429 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2021 | 1380 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2023 | 275 | 0.100 |
Why?
|
| Obesity | 2 | 2016 | 814 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2017 | 704 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 437 | 0.090 |
Why?
|
| Adolescent | 6 | 2017 | 3538 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 171 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2009 | 8 | 0.080 |
Why?
|
| School Nursing | 1 | 2009 | 1 | 0.080 |
Why?
|
| Adiposity | 1 | 2009 | 67 | 0.080 |
Why?
|
| Reference Values | 2 | 2024 | 87 | 0.080 |
Why?
|
| Young Adult | 4 | 2019 | 2465 | 0.080 |
Why?
|
| School Health Services | 1 | 2009 | 39 | 0.080 |
Why?
|
| Consumer Behavior | 1 | 2009 | 28 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 342 | 0.070 |
Why?
|
| Prevalence | 2 | 2025 | 840 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2020 | 1076 | 0.070 |
Why?
|
| Social Environment | 2 | 2021 | 85 | 0.070 |
Why?
|
| Prognosis | 3 | 2017 | 603 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 124 | 0.070 |
Why?
|
| Health Surveys | 2 | 2019 | 245 | 0.070 |
Why?
|
| Social Determinants of Health | 2 | 2020 | 38 | 0.060 |
Why?
|
| United Kingdom | 2 | 2016 | 25 | 0.060 |
Why?
|
| Sulfonylurea Compounds | 1 | 2025 | 25 | 0.060 |
Why?
|
| Audiometry | 1 | 2025 | 2 | 0.060 |
Why?
|
| Organ Size | 1 | 2025 | 16 | 0.060 |
Why?
|
| Brazil | 1 | 2025 | 10 | 0.060 |
Why?
|
| White Matter | 1 | 2024 | 2 | 0.060 |
Why?
|
| Self-Help Devices | 1 | 2024 | 2 | 0.060 |
Why?
|
| Medicare | 1 | 2025 | 192 | 0.050 |
Why?
|
| Medicaid | 1 | 2025 | 189 | 0.050 |
Why?
|
| Algorithms | 1 | 2025 | 223 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2023 | 5 | 0.050 |
Why?
|
| Death | 1 | 2023 | 10 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2023 | 3 | 0.050 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 476 | 0.050 |
Why?
|
| Insulin | 1 | 2023 | 188 | 0.050 |
Why?
|
| Schools | 1 | 2021 | 88 | 0.040 |
Why?
|
| Life Change Events | 1 | 2021 | 31 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2021 | 45 | 0.040 |
Why?
|
| Mexico | 1 | 2020 | 18 | 0.040 |
Why?
|
| Sleep Hygiene | 1 | 2020 | 2 | 0.040 |
Why?
|
| Causality | 1 | 2020 | 34 | 0.040 |
Why?
|
| Psychology | 1 | 2020 | 14 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2019 | 30 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 170 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2019 | 8 | 0.040 |
Why?
|
| Pharmacoepidemiology | 1 | 2019 | 18 | 0.040 |
Why?
|
| Exposure to Violence | 1 | 2019 | 9 | 0.040 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2019 | 46 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2020 | 306 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 43 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 384 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2019 | 149 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1098 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 13 | 0.030 |
Why?
|
| New Zealand | 1 | 2017 | 7 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 11 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 879 | 0.030 |
Why?
|
| Michigan | 1 | 2016 | 28 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 560 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 104 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 8 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 12 | 0.030 |
Why?
|
| Social Adjustment | 1 | 2015 | 13 | 0.030 |
Why?
|
| Emotions | 1 | 2015 | 34 | 0.030 |
Why?
|
| Heart Rate | 1 | 2015 | 38 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 672 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 82 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 206 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2017 | 375 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 804 | 0.030 |
Why?
|
| Anxiety | 1 | 2015 | 154 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 304 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 805 | 0.030 |
Why?
|
| Geography, Medical | 1 | 2013 | 4 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 1161 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 294 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2009 | 10 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 33 | 0.020 |
Why?
|
| Lipids | 1 | 2009 | 69 | 0.020 |
Why?
|
| Massachusetts | 1 | 2009 | 60 | 0.020 |
Why?
|
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->